Trial Profile
Efficacy And Safety Evaluation in Parkinson's Disease Monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Acronyms EASE-PD Monotherapy
- 05 Nov 2010 New trial record.